Labcorp

Labcorp is one of the largest clinical laboratory operators in the world, running an extensive network of diagnostic testing sites and offering drug development services to pharmaceutical clients through its former Covance business. Its scale in routine and specialized testing gives it a central role in the US healthcare system, from everyday blood work to advanced genomic and oncology diagnostics. Labcorp began paying a regular dividend only recently, so its history of increases is short and its yield remains low. Management has prioritized reinvestment and buybacks, treating the dividend as a supplementary return. The moderate score reflects a young payout backed by resilient healthcare demand but without the long track record that defines established income stocks.